References
- Bindoli A., Fleischer S. Induced Ca++ release in skeletal muscle sarcoplasmic reticulum by sulfhydryl reagents and chlorpromazine. Arch. Biochem. Biophys. 1983; 221: 458–466
- Bollet A. J., Beierwaltes W. H., Knopf R. F., et al. Extraocular muscle, skeletal muscle, and thyroid gland mucopolysaccharide response to thyroid-stimulating hormone. J. Lab. din. Med. 1961; 58: 884–891
- Medical Physiology, A. M. Brown, D. W. Stubbs. John Wiley and Sons, New York 1983; 70–80
- Cecchi G., Griffiths P. J., Taylor S. The kinetics of cross-bridge attachment and detachment studied by high frequency stiffness measurements. Adv. exp. Med. Biol. 1984; 170: 641–655
- Clusin W. T., Buchbinder M., Ellis A. K., et al. Reduction of ischemic depolarization by the calcium channel blocker diltiazem: correlation with improvement of ventricular conduction and early arrhythmias in the dog. Circ. Res. 1984; 54: 10–20
- Dyer J. A. The oculorotary muscles in Graves' disease. Trans. Amer. ophthal. Soc. 1976; 74: 425–456
- Enzmann D. R., Donaldson S. S., Kriss J. P. Appearance of Graves' disease on orbital computed tomography. J. Comp. assist. Tomogr. 1979; 3: 815–819
- Faulkner J. A., McCully K. K., Carlson D. S., et al. Contractile properties of the muscles of mastication in rhesus monkeys. (Macaca mulatto) following increase in muscle length. Arch. oral Biol. 1982; 27: 841–843
- Frank G. B. Roles of extracellular and ‘trigger’ calcium ions in excitation-contraction coupling in skeletal muscle. Canad. J. Physiol. Pharmacol. 1982; 60: 427–439
- Frueh B. R. Graves' eye disease: Orbital compliance and other physical measurements. Trans. Amer. ophthal. Soc. 1984; 82: 492–598
- Garay A., Mattiazzia A. Decrease in time to peak tension produced by calcium blockers and isoproterenol. Its dependence on extracellular calcium. Acta physiol. Latin Amer. 1982; 32: 295–302
- Gelpl R. J., Mosca S. M., Rinaldi G. J., et al. Effect of calcium antagonism on contractile behavior of canine hearts. Amer. J. Physiol. 1983; 244: H378–H386, (Heart Circ, Physiol, 13)
- Godfraind T., Finet M., Lima J. S., et al. Contractile activity of human coronary arteries and human myocardium in vitro and their sensitivities to calcium entry blockade by nifedipine. J. Pharmacol. exp. Ther. 1984; 230: 514–518
- Heikkila J., Nieminen M. S. Effects of verapamil in patients with acute myocardial infarction: hemodynamics and function of normal and ischemic left ventricular myocardium. Amer. Heart J. 1984; 107: 241–257
- Hufnagel T. J., Hickey W. F., Cobbs W. H., et al. Immunohistochemical and ultrastructural studies on the exenter-ated orbital tissues of a patient with Graves' eye disease. Ophthalmology 1984; 92: 1411–1419
- Kroll A. J., Kuwabara T. Dysthyroid ocular myopathy: anatomy, histology, and electron microscopy. Arch. Ophthal. 1966; 76: 244–257
- Kurita A., Isojima K., Mizuno K., et al. Effects of new calcium channel blocker of niludipine on the coronary hemodynamics, diastolic properties and metabolic responses to tachycardia stress in patients with coronary disease. Cathet. cardiovasc. Diagn. 1982; 8: 373–381
- Li T., Vassalle M. The negative inotropic effect of calcium overload in cardiac Purkinje fibers. J. mol. cell. Cardiol. 1984; 16: 65–77
- Robinson D. A., O'Meara D. M., Scott A. B., Collins C. C. Mechanical components of human eye movements. J. appl. Physiol. 1969; 26: 548–553
- Schwartz A., Triggle D. J. Cellular action of calcium channel blocking drugs. Ann. Rev. Med. 1984; 35: 325–339
- Sherrington C. S. Reciprocal innervation of antagonistic muscles. Proc. roy. Soc. London, Series B 1909; 91: 249–268
- Smith A. M. The coactivation of antagonist muscles. Canad. J. Physiol. Pharmacol. 1981; 59: 733–747
- Venter J. C., Fraser C. M., Schaber J. S., et al. Molecular properties of the slow inward calcium channel. J. biol. Chem. 1983; 258: 9344–9348